Gefitinib Inhibits Bleomycin-Induced Pulmonary Fibrosis via Alleviating the Oxidative Damage in Mice

Pulmonary fibrosis (PF) is a life-threatening interstitial lung disease. In this study, we tried to reveal the model of action between high-mobility group box 1 (HMGB1) and α-smooth muscle actin (α-SMA) and the protective role of gefitinib in pulmonary fibrosis induced by the administration of bleom...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Li, Cai, Lin, Zheng, Linxin, Hu, Yujie, Yuan, Weifeng, Guo, Zhenhui, Li, Weifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924979/
https://www.ncbi.nlm.nih.gov/pubmed/29849916
http://dx.doi.org/10.1155/2018/8249693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924979/
https://www.ncbi.nlm.nih.gov/pubmed/29849916
http://dx.doi.org/10.1155/2018/8249693

Ejemplares similares